Cyclogyl dilates the pupil, which can cause blurred vision and increased light sensitivity. It is safest to avoid driving or operating machinery until visual clarity returns, usually within 2-4 hours after the last drop.
Severe eye pain may indicate acute angle-closure glaucoma, a medical emergency. Seek immediate ophthalmic care or go to the nearest emergency department.
Remove contact lenses before instilling Cyclogyl. Re-insert lenses only after the drug’s effect has worn off and the eye feels comfortable, typically after several hours.
Pupil dilation generally lasts between 6 and 24 hours, varying with age, dosage, and individual response. Younger patients may experience a longer duration.
Cyclogyl is classified as Category C in the UK, meaning risk cannot be ruled out. It should only be used during pregnancy when the potential benefit justifies the potential risk, and after consulting a healthcare professional.
The original Cyclogyl bottle is a clear plastic container with a distinct white label that reads “CYCLOGYL 1 % EYE DROPS” and includes the MHRA batch number and expiry date printed on the base.
Cyclopentolate has anticholinergic properties. Concurrent use of systemic antihistamines, which also possess anticholinergic effects, may increase the likelihood of dry mouth, flushing, or tachycardia. Monitor symptoms and discuss any concerns with your clinician.
Do not pour the solution down the drain. Return any unused or expired medication to a pharmacy’s disposal program, or follow local council guidelines for safe drug disposal.
Yes, cyclopentolate 1 % eye drops are available as a generic product. Both brand-name and generic formulations contain the same active ingredient and concentration; however, excipients may differ slightly.
Exposure to temperatures above 30 °C or freezing conditions can degrade the drug’s potency and alter its appearance. Store the medication at room temperature, away from direct sunlight and heat sources.
Cyclogyl is a brand-name ophthalmic solution that contains the active ingredient cyclopentolate at a concentration of 1 %. It belongs to the eye-care therapeutic class and is supplied as a sterile drop formulation. In the United Kingdom Cyclogyl is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It is commonly used by eye-care professionals to temporarily dilate the pupil (mydriasis) and to temporarily paralyse the ciliary muscle (cycloplegia) for diagnostic examinations of the eye.
Cyclopentolate is an anticholinergic agent that blocks the muscarinic receptors of the iris sphincter and ciliary muscles. By preventing acetylcholine from binding:
The drug is absorbed through the cornea, and its onset of action typically begins within 5-15 minutes, reaching maximal effect at 20-30 minutes. The duration of mydriasis and cycloplegia usually lasts 6-24 hours, depending on the individual’s age and ocular health. Because cyclopentolate is a reversible anticholinergic, its effects wear off as the drug is metabolised and cleared from ocular tissues.
Cyclogyl is approved in the UK for the following indications:
These uses are endorsed by the MHRA and are reflected in the product’s Summary of Product Characteristics (SPC).
Research has explored additional applications of cyclopentolate, though they remain off-label in the UK:
Disclaimer: Off-label use requires medical supervision and individualized risk assessment. Cyclogyl should only be employed for these purposes when a qualified eye-care professional determines that the potential benefits outweigh the risks.
If any of these conditions apply, the prescribing clinician should consider alternative agents or adjust the treatment plan.
Safety Note: Patients should inform their eye-care provider of all medicines, supplements, and herbal products they are using before starting Cyclogyl.
This article provides educational information about Cyclogyl and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
